Opportunity Information: Apply for CDC RFA CK12 1201
Apply for CDC RFA CK12 1201
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Epidemiology and Laboratory Capacity (ELC) for Infectious Diseases Program Components" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on Jul 17, 2012 and posted on Aug 23, 2011.
- Applicants must submit their applications by Aug 1, 2012 Not a solicatation for applications.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $225,000,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 58 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau). Official public health agencies of city governments with jurisdictional populations greater than 1,500,000 or county governments with jurisdictional populations greater than 8,000,000 (based on 2010 Census data). This includes only the following Chicago IL, Houston TX, Los Angeles County CA, New York City NY, and Philadelphia PA
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Epidemiology and Laboratory Capacity (ELC) for Infectious Diseases Program Components opportunity (Funding Opportunity Number CDC RFA CK12-1201) is a CDC cooperative agreement designed to help public health agencies strengthen how they detect, track, and respond to infectious diseases and other public health threats. In practical terms, the program is meant to build and sustain the core capabilities that health departments rely on during outbreaks and routine disease monitoring. The stated purpose is fivefold: strengthening epidemiologic capacity, enhancing laboratory capacity, improving information systems, developing and implementing prevention and control strategies, and improving coordination across epidemiology, laboratory, and informatics functions within public health departments. The emphasis is on better surveillance and faster, more effective response, which usually translates into improvements in staffing, workflows, systems, and cross-team collaboration.
This funding was offered as a discretionary award under the “Health†activity category, using a cooperative agreement mechanism. A cooperative agreement generally means the CDC expects substantial involvement during the period of performance, such as providing technical guidance, setting program expectations, and working with recipients on implementation approaches, performance monitoring, and outcomes. The listing references CFDA 93.283 (Centers for Disease Control and Prevention: Investigations and Technical Assistance). There is no cost sharing or matching requirement indicated, lowering the financial barrier for eligible public agencies to participate.
The opportunity anticipated 58 awards with an estimated total funding amount of $225,000,000. The notice does not specify an award ceiling or floor (both are listed as 0), which typically indicates award amounts may vary by jurisdiction, program component, or CDC allocation decisions rather than being constrained by a single published cap. Timing details show it was posted August 23, 2011, with an original closing date of October 21, 2011, and a later “current closing date†of August 1, 2012, followed by an archive date of August 2, 2012. The record also states it is “Not a solicitation for applications,†which often signals this entry may reflect an administrative update, continuation, or a funding action that is not open for general competition at the time it was listed, even though it contains standard opportunity fields.
Eligibility centers on governmental public health entities. Eligible applicants include state and local governments or their bona fide agents, explicitly including U.S. territories and freely associated states listed in the notice: the District of Columbia, Puerto Rico, the U.S. Virgin Islands, the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau. In addition, certain large local health departments are specifically eligible based on jurisdictional population thresholds from 2010 Census data: official public health agencies of city governments serving populations greater than 1,500,000 or county governments serving populations greater than 8,000,000. The announcement narrows this to a defined set of jurisdictions: Chicago, Illinois; Houston, Texas; Los Angeles County, California; New York City, New York; and Philadelphia, Pennsylvania.
Programmatically, the ELC structure points to investments in people, systems, and coordination that directly affect readiness and response. Strengthening epidemiologic capacity commonly involves improving disease investigation capability, outbreak detection and response, analytic capacity, and the ability to translate surveillance findings into public health action. Enhancing laboratory capacity typically includes improving diagnostic testing capability, quality systems, surge capacity during outbreaks, and linkages between clinical and public health labs. Improving information systems highlights the need for modern, reliable data flows, better reporting and interoperability, and tools that support timely analysis and situational awareness. Developing and implementing prevention and control strategies underscores that the end goal is not just data collection, but actionable interventions and public health measures. Finally, the explicit focus on collaboration among epidemiology, laboratory, and information systems functions reflects the reality that effective infectious disease response depends on these units working as an integrated system rather than in parallel silos.
The sponsoring agency is the Centers for Disease Control and Prevention. The notice indicates the additional information link was not active and instructs users to use the “Full Announcement†tab (as it appeared in the original posting environment). For access issues, it provides a point of contact at the CDC Procurement and Grants Office, Technical Information and Management Section, with a phone number (770-488-2700) for general submission inquiries and assistance accessing the full announcement electronically.
Frequently Asked Questions (FAQs)
1. What is the ELC for Infectious Diseases Program Components opportunity?
The Epidemiology and Laboratory Capacity (ELC) for Infectious Diseases Program Components opportunity (Funding Opportunity Number CDC RFA CK12-1201) is a CDC cooperative agreement intended to help public health agencies strengthen how they detect, track, and respond to infectious diseases and other public health threats.
2. What is the main goal of this program in practical terms?
In practical terms, the program is designed to build and sustain core public health capabilities used for routine disease monitoring and for responding to outbreaks. It focuses on improving readiness and response by strengthening staffing, workflows, systems, and cross-team collaboration within health departments.
3. What are the stated purpose areas of the opportunity?
The stated purpose is fivefold: (1) strengthening epidemiologic capacity, (2) enhancing laboratory capacity, (3) improving information systems, (4) developing and implementing prevention and control strategies, and (5) improving coordination across epidemiology, laboratory, and informatics functions within public health departments.
4. What type of funding mechanism is used?
This opportunity uses a cooperative agreement mechanism. That generally means the CDC expects substantial involvement during the period of performance, such as providing technical guidance, setting program expectations, working with recipients on implementation approaches, and supporting performance monitoring and outcomes.
5. Is this a discretionary award, and what category does it fall under?
Yes. It was offered as a discretionary award under the "Health" activity category.
6. What CFDA number is associated with this opportunity?
The listing references CFDA 93.283 (Centers for Disease Control and Prevention: Investigations and Technical Assistance).
7. Is cost sharing or matching required?
No cost sharing or matching requirement is indicated in the information provided.
8. How much funding was estimated for this opportunity?
The opportunity anticipated an estimated total funding amount of $225,000,000.
9. How many awards were anticipated?
The opportunity anticipated 58 awards.
10. Is there a published minimum or maximum award amount?
No. The notice lists both the award ceiling and award floor as 0, which typically indicates award amounts may vary by jurisdiction, program component, or CDC allocation decisions rather than being constrained by a single published cap.
11. What were the key dates listed for this opportunity?
The opportunity was posted on August 23, 2011. It shows an original closing date of October 21, 2011, a later "current closing date" of August 1, 2012, and an archive date of August 2, 2012.
12. Does the listing indicate it is open for applications?
The record states it is "Not a solicitation for applications," which often signals the entry may reflect an administrative update, continuation, or a funding action that is not open for general competition at the time it was listed, even if standard opportunity fields appear.
13. Who is eligible to apply?
Eligibility centers on governmental public health entities. Eligible applicants include state and local governments or their bona fide agents.
14. Are U.S. territories and freely associated states included as eligible applicants?
Yes. The notice explicitly includes the District of Columbia, Puerto Rico, the U.S. Virgin Islands, the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau.
15. Are any specific large local health departments explicitly eligible?
Yes. Certain large local health departments are specifically eligible based on 2010 Census population thresholds: official public health agencies of city governments serving populations greater than 1,500,000 or county governments serving populations greater than 8,000,000.
16. Which specific jurisdictions are named as eligible large local health departments?
The announcement narrows this to a defined set of jurisdictions: Chicago, Illinois; Houston, Texas; Los Angeles County, California; New York City, New York; and Philadelphia, Pennsylvania.
17. What kinds of activities are implied under strengthening epidemiologic capacity?
Strengthening epidemiologic capacity commonly involves improving disease investigation capability, outbreak detection and response, analytic capacity, and the ability to translate surveillance findings into public health action.
18. What kinds of activities are implied under enhancing laboratory capacity?
Enhancing laboratory capacity typically includes improving diagnostic testing capability, quality systems, surge capacity during outbreaks, and linkages between clinical and public health labs.
19. What does "improving information systems" refer to in this opportunity?
Improving information systems highlights the need for modern, reliable data flows, better reporting and interoperability, and tools that support timely analysis and situational awareness.
20. Why does the opportunity emphasize coordination across epidemiology, laboratory, and informatics?
The opportunity explicitly focuses on collaboration among epidemiology, laboratory, and information systems functions because effective infectious disease surveillance and response depend on these units working as an integrated system rather than in parallel silos.
21. Who is the sponsoring agency?
The sponsoring agency is the Centers for Disease Control and Prevention (CDC).
22. What should applicants do if the additional information link is not active?
The notice indicates the additional information link was not active and instructs users to use the "Full Announcement" tab (as it appeared in the original posting environment).
23. Who can be contacted for help accessing the full announcement or for submission inquiries?
The notice provides a point of contact at the CDC Procurement and Grants Office, Technical Information and Management Section. For general submission inquiries and assistance accessing the full announcement electronically, the phone number listed is 770-488-2700.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Human Heredity and Health in Africa (H3Africa) Collaborative Centers (U54)
Previous opportunity: Native and Endangered Plant Restoration, Perpetuation and Care at Kaloko Honokohau National Historical Park
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA CK12 1201
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA CK12 1201) also looked into and applied for these:
| Funding Opportunity |
|---|
| Human Heredity and Health in Africa (H3Africa) Bioinformatics Network (U41) Apply for RFA RM 11 010 Funding Number: RFA RM 11 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| GIRLS EMPOWERMENT AND INNOVATIONS IN YOUTH, REPRODUCTIVE HEALTH, AND FAMILY PLANNING, AND SERVICE OUTREACH Apply for USAID TANZANIA 11 007 APS Funding Number: USAID TANZANIA 11 007 APS Agency: Tanzania USAID Dar es Salaam Category: Health Funding Amount: $14,000,000 |
| Resource Centers for Minority Aging Research (RCMAR) and Coordinating Center (P30) Apply for RFA AG 12 012 Funding Number: RFA AG 12 012 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Single Cell Studies in Aging Research (R01) Apply for PA 11 320 Funding Number: PA 11 320 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Single Cell Studies in Aging Research (R21) Apply for PA 11 321 Funding Number: PA 11 321 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Mentored Career Development Award to Promote Faculty Diversity/Re Entry in Biomedical Research (K01) Apply for RFA HL 12 030 Funding Number: RFA HL 12 030 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Training for States on Winnable Battles Apply for CDC RFA DP08 8030401SUPP11 Funding Number: CDC RFA DP08 8030401SUPP11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Comprehensive, Integrated, and Sustainable HIV/AIDS Services Apply for USAID TANZANIA 11 008 APS Funding Number: USAID TANZANIA 11 008 APS Agency: Tanzania USAID Dar es Salaam Category: Health Funding Amount: $100,000,000 |
| T32 Training Program for Institutions That Promote Diversity (T32) Apply for RFA HL 12 032 Funding Number: RFA HL 12 032 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Neurosurgeon Research Career Development Program (NRCDP) (K12) Apply for RFA NS 12 008 Funding Number: RFA NS 12 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| PEPFAR Caribbean HIV/AIDS Regional Training Initiative (CHART II) Apply for HRSA 12 103 Funding Number: HRSA 12 103 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Understanding Mechanisms of Terminal Erythroid Maturation (R01) Apply for RFA HL 12 033 Funding Number: RFA HL 12 033 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Reducing Loss to Follow up after Failure to Pass Newborn Hearing Screening Apply for HRSA 12 047 Funding Number: HRSA 12 047 Agency: Health Resources and Services Administration Category: Health Funding Amount: $250,000 |
| Teaching Health Center Graduate Medical Education (THCGME) Program Apply for HRSA 12 029 Funding Number: HRSA 12 029 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| CDCs Collaboration with Academia to Strengthen Public Health Workforce Capacity Apply for CDC RFA OE12 1201 Funding Number: CDC RFA OE12 1201 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Bright Futures Pediatric Implementation Cooperative Agreement Apply for HRSA 12 068 Funding Number: HRSA 12 068 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| FY12 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Ohio) Apply for PA FPH 12 011 Funding Number: PA FPH 12 011 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $4,168,578 |
| Immunopathogenesis of HIV/AIDS related Oral Manifestations and Host Immunity (R21) Apply for PA 11 333 Funding Number: PA 11 333 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Immunopathogenesis of HIV/AIDS related Oral Manifestations and Host Immunity (R01) Apply for PA 11 334 Funding Number: PA 11 334 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD) (U01) Apply for RFA AA 12 004 Funding Number: RFA AA 12 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA CK12 1201", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.